- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02049658
The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients
February 6, 2024 updated by: Chang-Qing Gao
Previous studies have demonstrated that sniff dogs can identify cancer patients from healthy subjects through sniffing exhaled breath air or blood or serum or urine or feces.
It is hypothesized that sniff dogs may be used as a tool in identifying cancer patients in the high risk population or suspected patients.
Trained dogs will sniff serum from participants who are suspected to suffer from tumor by their physicians and not yet but will be diagnosed by pathological examination.The results will be compared with the outcome of the pathological examination.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
2000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ya-Qin Wang, MD PhD
- Phone Number: 86 15274810930
- Email: wdove.bb@163.com
Study Contact Backup
- Name: Chang-Qing Gao, MD PhD
- Phone Number: 86 188 7486 9488
- Email: cgao851@126.com
Study Locations
-
-
Hunan
-
Changsha, Hunan, China, 410008
- Recruiting
- Center for Scientific Research with Animal Models, CSU
-
Contact:
- Ya-Qin Wang, MD PhD
- Phone Number: 152 7481 0930
- Email: wdove.bb@163.com
-
Contact:
- Chang-Qing Gao, MD PhD
- Phone Number: 86 188 7486 9488
- Email: cgao851@126.com
-
Principal Investigator:
- Chang-Qing Gao, MD PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
- Healthy volunteers who have been examined by the currently used procedures and find to be without tumors.
- Patients in the breast surgery, thoracic surgery, gynecological and neurosurgery departments with lesions with characteristics of tumors
Description
Inclusion Criteria:
- Healthy volunteers who have been examined by the currently used procedures and find to be without tumors.
- Patients in the breast surgery, thoracic surgery, gynecological and neurosurgery departments with lesions with characteristics of tumors
Exclusion Criteria:
- Patients who have had pathological results
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Healthy volunteers
Healthy volunteers measured by currently used healthy screening procedures
|
Suspected breast cancer subjects
Suspected breast cancer subjects without pathological examination yet but will have it soon
|
Suspected lung cancer subjects
Suspected lung cancer subjects without pathological examination yet but will have it soon
|
Suspected neurological tumor subjects
Suspected neurological tumor subjects without pathological examination yet but will have it soon
|
Suspected patients with gynecological tumor
Suspected subjects with gynecological tumors without pathological examination yet but will have it soon
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
sensitivity and specificity of the sniff dogs as a tool in diagnosing tumors
Time Frame: 12 months
|
The results that obtained from the dogs will be compared with these of the pathological examinations.
Sensitivity = the No. of patients identified by the dogs as cancers / the No. of patients suffering from cancer confirmed by pathological examination.
Specificity = No. of subjects signaled by the dog as non-cancers / No. of subjects confirmed by pathological examination as non-cancer subjects.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
behavior patterns of the sniff dogs to different diseases
Time Frame: 12 months
|
The behavior (lying before the tank for positive, neglecting the tanks) of the dog will be recorded and compared with the results of the pathological examination.
|
12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the substances used for identifying tumors by the sniff dogs
Time Frame: 12 months
|
GCMS etc will be used to compare the volatile compounds between the sera from cancers patients and the from non-cancer subjects, the suspected VOCs will be tested by the dog for conformation.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Chang-Qing Gao, MD PhD, Central South University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Estimated)
December 31, 2025
Study Completion (Estimated)
December 1, 2026
Study Registration Dates
First Submitted
January 26, 2014
First Submitted That Met QC Criteria
January 28, 2014
First Posted (Estimated)
January 30, 2014
Study Record Updates
Last Update Posted (Actual)
February 8, 2024
Last Update Submitted That Met QC Criteria
February 6, 2024
Last Verified
February 1, 2024
More Information
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neoplasia
-
Krankenhaus Barmherzige Schwestern LinzMedical University of ViennaCompletedCervical Intraepithelial Neoplasia Grade 1 | Cervical Intraepithelial Neoplasia Grade 2Austria
-
Coordinación de Investigación en Salud, MexicoUniversity of Guadalajara; Instituto Mexicano del Seguro SocialCompletedConjunctival Intraepithelial Neoplasia | Corneal Intraepithelial NeoplasiaMexico
-
University Hospital, GenevaCompletedCervical Intra-epithelial Neoplasia Grade 1 or WorseSwitzerland
-
Genexine, Inc.CompletedCervical Intraepithelial Neoplasia 3Korea, Republic of
-
Mithra PharmaceuticalsCompletedCervix Intraepithelial Neoplasia | Uterine Cervical NeoplasiaBelgium
-
Nykode Therapeutics ASATheradex; Vaccibody ASCompletedHigh Grade Cervical Intraepithelial NeoplasiaGermany
-
University of Alabama at BirminghamNational Cancer Institute (NCI)CompletedHigh-grade Cervical Intraepithelial NeoplasiaUnited States
-
National Cancer Institute (NCI)Terminated
-
Hôpital Edouard HerriotCompletedColorectal NeoplasiaFrance
-
ViMREX GmbHFrankfurter Institut für Klinische Krebsforschung IKF GmbH am Krankenhaus...Active, not recruitingVulvar Intraepithelial Neoplasia Grade 2 | Vulvar Intraepithelial Neoplasia Grade 3Germany